PubMed

Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.

Hohberg C, Forst T, Larbig M, Safinowski M, Diessel S, Hehenwarter S, Weber MM, Schöndorf T, Pfützner A.

Diabetes Care. 2008 May;31(5):1021-5. Epub 2008 Feb 11.PMID: 18268067 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.

Forst T, Forst S, Strunk K, Löbig M, Welter K, Kazda C, Pfützner A.

J Diabetes Complications. 2005 May-Jun;19(3):128-32.PMID: 15866056 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

Danne T, Becker RH, Heise T, Bittner C, Frick AD, Rave K.

Diabetes Care. 2005 Sep;28(9):2100-5.PMID: 16123473 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.

Forst T, Lübben G, Hohberg C, Kann P, Sachara C, Gottschall V, Friedrich C, Rosskopf R, Pfützner A.

Microcirculation. 2005 Oct-Nov;12(7):543-50.PMID: 16207627 [PubMed - indexed for MEDLINE]Related articles

Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study.

Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N.

J Clin Endocrinol Metab. 2006 Mar;91(3):837-42. Epub 2005 Dec 20.PMID: 16368744 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.

Luzio S, Peter R, Dunseath GJ, Mustafa L, Owens DR.

Diabetes Res Clin Pract. 2008 Feb;79(2):269-75. Epub 2007 Dec 27.PMID: 18164094 [PubMed - indexed for MEDLINE]Related articles

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.

Hanefeld M, Haffner SM, Menschikowski M, Koehler C, Temelkova-Kurktschiev T, Wildbrett J, Fischer S.

Diabetes Res Clin Pract. 2002 Mar;55(3):221-7.PMID: 11850098 [PubMed - indexed for MEDLINE]Related articles

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients.

Scognamiglio R, Negut C, de Kreutzenberg SV, Tiengo A, Avogaro A.

Diabetes Care. 2006 Jan;29(1):95-100.PMID: 16373903 [PubMed - indexed for MEDLINE]Related articlesFree article

Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.

Rave K, Klein O, Frick AD, Becker RH.

Diabetes Care. 2006 Aug;29(8):1812-7.PMID: 16873785 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes.

Rayman G, Profozic V, Middle M.

Diabetes Res Clin Pract. 2007 May;76(2):304-12. Epub 2006 Nov 20.PMID: 17113676 [PubMed - indexed for MEDLINE]Related articles

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.

Vehkavaara S, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):325-30. Epub 2003 Dec 18.PMID: 14684428 [PubMed - indexed for MEDLINE]Related articlesFree article

Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.

Rosak C, Hofmann U, Paulwitz O.

Diabetes Nutr Metab. 2004 Jun;17(3):137-42.PMID: 15334790 [PubMed - indexed for MEDLINE]Related articles

Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study.

Rizzo MR, Barbieri M, Grella R, Passariello N, Paolisso G.

Diabetes Metab. 2005 Jun;31(3 Pt 1):255-60.PMID: 16142016 [PubMed - indexed for MEDLINE]Related articlesFree article

The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart.

Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E.

Diabet Med. 2004 Feb;21(2):171-5.PMID: 14984453 [PubMed - indexed for MEDLINE]Related articles

Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.

Diabetes Care. 2003 Feb;26(2):502-9.PMID: 12547889 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes.

Ceriello A, Piconi L, Quagliaro L, Wang Y, Schnabel CA, Ruggles JA, Gloster MA, Maggs DG, Weyer C.

Diabetes Care. 2005 Mar;28(3):632-7.PMID: 15735200 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of Fuscoporia obliqua on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients.

Maenaka T, Oshima M, Itokawa Y, Masubuchi T, Takagi Y, Choi JS, Ishida T, Gu Y.

J Tradit Chin Med. 2008 Mar;28(1):49-57.PMID: 18416085 [PubMed - indexed for MEDLINE]Related articles

Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.

Guevara-Aguirre J, Guevara M, Saavedra J, Mihic M, Modi P.

Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):472-8.PMID: 15386822 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine.

Robinson DM, Wellington K.

Drugs. 2006;66(6):861-9.PMID: 16706558 [PubMed - indexed for MEDLINE]Related articles